Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity
Abstract Background Radiation therapy and chemoradiation therapy play a major role in the definitive management of esophageal cancer. Survival in esophageal cancer patients is still relatively poor, mostly due to high rates of local recurrence and distant metastases. It is hypothesized that dose esc...
Main Authors: | J. Ristau, M. Thiel, S. Katayama, I. Schlampp, K. Lang, M. F. Häfner, K. Herfarth, J. Debus, S. A. Koerber |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13014-021-01749-x |
Similar Items
-
Elective Node Irradiation With Integrated Boost to the Prostate Using Helical IMRT–Clinical Outcome of the Prospective PLATIN-1 Trial
by: Stefan Alexander Koerber, et al.
Published: (2019-08-01) -
IMRT with the Use of Simultaneous Integrated Boost in Treatment of Head and Neck Cancer: Acute Toxicity Evaluation
by: Milan Vošmik, et al.
Published: (2006-01-01) -
Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost for Clinically Node-Positive Prostate Cancer: A Single-Institutional Retrospective Study
by: Masahiro Onishi, et al.
Published: (2021-07-01) -
Retrospective feasibility study of simultaneous integrated boost in cervical cancer using tomotherapy: the impact of organ motion and tumor regression
by: Herrera Fernanda G, et al.
Published: (2013-01-01) -
Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis
by: Chen Li, et al.
Published: (2021-06-01)